Results of open prospective study of clinical assessment of efficacy and safety of Nifuratel during exacerbations of recurrent cystitis
https://doi.org/10.33667/2078-5631-2021-32-20-24
Abstract
The article presents the results of an open prospective study of the clinical assessment of the efficacy and safety of the use of nifuratel during exacerbations of recurrent cystitis. The aim of the program was to assess the change in the duration of the relapse-free course of recurrent cystitis and the effectiveness of the course treatment with Nifuratel-SZ in the treatment of recurrent cystitis. During a non-interventional program, Nifuratel-SZ has been shown to be an effective and well-tolerated drug for the treatment of recurrent uncomplicated lower urinary tract infection.
About the Authors
Z. V. Moskvina
First Moscow State Medical University n. a. I. M. Sechenov
Russian Federation
Russian Federation
Moskvina Zoya V.
Moscow
M. S. Evdokimov
‘Family Polyclinic No. 4’ Co.
Russian Federation
Russian Federation
Evdokimov Mikhail S.
Moscow
L. G. Spivak
First Moscow State Medical University n. a. I. M. Sechenov
Russian Federation
Russian Federation
Spivak Leonid G.
Scopus: 57196177636
Moscow
References
1. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001; 183. Suppl 1: S 1–S 4. DOI: 10.1086/318850.
2. Kolman KB. Cystitis and Pyelonephritis: Diagnosis, Treatment, and Prevention. Prim Care. 2019; 46 (2): 191–202. DOI: 10.1016/j.pop.2019.01.001.
3. Kladenský J. Urinary tract infections in women – possibilities of differentiated approach in treatment and prevention. Ceska Gynekol. 2012; 77 (1): 5–9.
4. Vecchio M, Iroz A, Seksek I. Prevention of Cystitis: Travelling between the Imaginary and Reality. Ann Nutr Metab. 2018; 72 Suppl 2: 8–10. DOI: 10.1159/000488224.
Review
For citations:
Moskvina Z.V., Evdokimov M.S., Spivak L.G. Results of open prospective study of clinical assessment of efficacy and safety of Nifuratel during exacerbations of recurrent cystitis. Medical alphabet. 2021;(32):20-24. (In Russ.) https://doi.org/10.33667/2078-5631-2021-32-20-24
Views:
352
Email this article 